Stock 600079 HUMANWELL HEALTHCARE (GROUP) CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Humanwell Healthcare (Group) Co.,Ltd.

Equities

600079

CNE000000QW6

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 02/07/2024 BST 		5-day change 1st Jan Change
16.55 CNY -2.47% Intraday chart for Humanwell Healthcare (Group) Co.,Ltd. -5.32% -33.43%
06-14 Humanwell Healthcare's Unit Gets Regulatory Nod to Trial Brivaracetam Tablets MT
05-22 Space Peptides announced that it has received funding from Humanwell Healthcare Co.,Ltd., Shenyang Xingqi Pharmaceutical Co.,Ltd., Xiamen Furuier Pharmaceutical Co., Ltd., Purple Knight Capital and other investors CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Humanwell Healthcare's Unit Gets Regulatory Nod to Trial Brivaracetam Tablets
Humanwell Healthcare's Unit Gets FDA's Nod to Market Two Drugs
Humanwell Healthcare's Unit Gets Nod to Strengthen Oxycodone Hydrochloride Tablets' Dosage
Humanwell Healthcare's Q1 Profit Falls 27%
Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Humanwell Healthcare's Profit Drops, Operating Income Climbs in 2023
Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
China Approves Sale of Humanwell Healthcare Unit's Prostate Cancer Treatment
Humanwell Healthcare's Subsidiary Gets Nod to Register Idecalcidol Soft Capsules
Production Line of Humanwell Healthcare's Unit Passes UK Drug Regulator's Inspection
Humanwell Healthcare Co.,Ltd. completed the acquisition of essential business operations of PAION AG and PAION Deutschland GmbH.
Humanwell Healthcare's Subsidiary Gets Nod to Register Anesthesia Drug
Humanwell Healthcare's Unit Enters Phase II Trial of Gout Drug
Humanwell Unit Gets China Registration Certificate for Drug to Prevent Renal Allograft Rejection
Humanwell Healthcare Gets Registration Approval for Pain Medication
Humanwell Healthcare's Unit Gets Nod for Registration of Acetaminophen Mannitol Injection
Humanwell Healthcare's Unit to Trial Naltrexone Bromide Tablets
Humanwell Healthcare Registers Anesthesia Drug
Humanwell Healthcare Registers Blood Clot Drug
Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600079 Stock
  4. News Humanwell Healthcare (Group) Co.,Ltd.
  5. Other languages